RT @UREssien: See more of the leading research from each of these Professors of Medicine below. 👇🏾👇🏾 🟡 Dr. White in @JAMA_current: https:/…
See more of the leading research from each of these Professors of Medicine below. 👇🏾👇🏾 🟡 Dr. White in @JAMA_current: https://t.co/B7TfGFp04x 🟡 Dr. @jsross119 in @JAMAInternalMed: https://t.co/qN4AcguHks 🟡 Dr. @SonyaBorrero: https://t.co/zxCddrO5nJ #Pha
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have generally declined, although these costs remain substantial and may be a significant financial burden for Medicare beneficiaries. https://t.co/a
RT @cynthiaboyd16: Loves this creative article. This is real for so many of my patients. @JHGeriatrics
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @cynthiaboyd16: Loves this creative article. This is real for so many of my patients. @JHGeriatrics
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @cynthiaboyd16: Loves this creative article. This is real for so many of my patients. @JHGeriatrics
RT @MikeSteinman: How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better…
RT @cynthiaboyd16: Loves this creative article. This is real for so many of my patients. @JHGeriatrics
Loves this creative article. This is real for so many of my patients. @JHGeriatrics
How much to Medicare patients pay out-of-pocket for drug costs for common conditions - and is the problem getting better or worse? Varies tremendously by which condition - new study: https://t.co/DKf3G4a7TG Brief thread... 1/n https://t.co/yPvfMpg6yh
RT @hillypaige2: #PartDReform #OOPCap #FinancialToxicity Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions…
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019 | Geriatrics | JAMA Internal Medicine | JAMA Network https://t.co/sMKCHN0AYd
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
Finding alternatives for prescriptions can be very important for patients with chronic illnesses especially as OOP costs change. We offer a #formulary navigator so doctors can find alternatives for their patients with #Medicare.
RT @UREssien: Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older ad…
Important new paper from @jsross119 & team. The estimated % change in OOP costs for guideline-recommended meds for older adults in Medicare over the past decade is 🤯. 🔴 HFrEF: 280% 🔴 Diabetes: 477% 🔴 AFib: 1634% (!!) #Pharmacoequity Link: https:
#PartDReform #OOPCap #FinancialToxicity Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/yi6FGzPDUu via @JAMAInternalMed part of @JAMANetwork @NatForumHDSP @AmerMedicalAssn @ABCardio1 @ASPCardio @BMAlliance @
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
Essential reading 👇👇
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
RT @reshmagar: Building off our paper in @JAMAInternalMed led by 🌟@YaleMed student Tianna Zhou, @jsross119, Tianna, & I write in @statnews…
RT @reshmagar: Building off our paper in @JAMAInternalMed led by 🌟@YaleMed student Tianna Zhou, @jsross119, Tianna, & I write in @statnews…
Building off our paper in @JAMAInternalMed led by 🌟@YaleMed student Tianna Zhou, @jsross119, Tianna, & I write in @statnews about how our findings highlight the urgency for Congress to pass structural reforms to lower drug prices as in #BuildBackBetter
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
“…. out-of-pocket costs remained high and may have presented a substantial financial burden for Medicare beneficiaries, especially older adults with conditions for which brand-name drugs were guideline recommended.” https://t.co/JjzGPrscXH
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findin…
For those of you interested in "bonus content", @reshmagar, Tianna and I wrote an OpEd for @statnews to summarize our findings in the context of the recent Part B premium increase and #BBB drug pricing proposals https://t.co/RoJaxKxNqP
Research reveals that for older adults with eight chronic conditions, annual out-of-pocket costs increased more than 40% between 2009 and 2019. https://t.co/rgvIYJOYww
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @SaurabhSDani: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/fBCTQUdTo2 via @JAMAInter…
Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/fBCTQUdTo2 via @JAMAInternalMed part of @JAMANetwork Out of pocket costs increased for older adults with Medicare PDP's #StupidPrice #RightPrice #PriceTranspare
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @FormigaFrancesc: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @FormigaFrancesc: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de…
RT @FormigaFrancesc: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
Damn.
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
Creative and important piece demonstrating the limitations of Part D coverage. Now if only Congress could get their act together and fix this!! #BuildBackBetter
RT @FormigaFrancesc: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
RT @jsross119: New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket cos…
New paper out today led by amazing @YaleMed student Tianna Zhou. We used @CMSGov formulary data to examine out-of-pocket costs associated with use of recommended medications by older adults with multiple chronic conditions (1/8) https://t.co/8XIu7Sk3Kg via
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
*Guideline* recommended therapy can lead to signficant out of pocket costs to patients w/ multiple conditions. Universal #pharmacare & #BasicIncome is essential health care. https://t.co/09ooYK4dhz via @JAMAInternalMed part of @JAMANetwork
RT @FormigaFrancesc: Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de…
Costs of Recommended Medications for Older Adults With Multiple Chronic Conditions https://t.co/bN9eSqFq5F a través de @JAMAInternalMed of @JAMANetwork @i_lozanomontoya @PilarCubo @ivmaroto_nacho @martinezvelilla @jaumepadros @macesari @roca_ferran @jagarc
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
Recent study from @JAMAInternalMed looking at out of pocket costs in US for chronic conditions. Although decreasing in general, still substantial for patients. Important study led by @jsross119 and colleagues, would be interesting to see in other countries
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
RT @JAMAInternalMed: Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have genera…
Out-of-pocket costs of guideline-recommended medications for older adults with multiple chronic conditions have generally declined, although these costs remain substantial and may be a significant financial burden for Medicare beneficiaries. https://t.co/T